We are live on ! Find out more
ONC

BeOne Medicines Ltd

266 hedge funds and large institutions have $19.1B invested in BeOne Medicines Ltd in 2021 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 109 increasing their positions, 77 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 17

42% more repeat investments, than reductions

Existing positions increased: 109 | Existing positions reduced: 77

6% more funds holding

Funds holding: 251266 (+15)

0.12% less ownership

Funds ownership: 4.77%4.65% (-0.12%)

2% less capital invested

Capital invested by funds: $19.5B → $19.1B (-$455M)

8% less funds holding in top 10

Funds holding in top 10: 1211 (-1)

11% less call options, than puts

Call options by funds: $10.2M | Put options by funds: $11.4M

Holders
266
Holders Change
+15
Holders Change %
+5.98%
% of All Funds
4.63%
Holding in Top 10
11
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-8.33%
% of All Funds
0.19%
New
34
Increased
109
Reduced
77
Closed
17
Calls
$10.2M
Puts
$11.4M
Net Calls
-$1.27M
Net Calls Change
+$58M
Name Holding Trade Value Shares
Change
Change in
Stake
SEI Investments
126
SEI Investments
Pennsylvania
$2.21M -$54.3K -164 -2%
VIA
127
Vident Investment Advisory
Georgia
$2.09M -$1.05M -3,172 -34%
Nomura Holdings
128
Nomura Holdings
Japan
$2.08M -$66.2K -200 -3%
GIBU
129
Gulf International Bank (UK)
United Kingdom
$2.06M
SAM
130
Sectoral Asset Management
Quebec, Canada
$2.06M +$66.2K +200 +3%
State of Wisconsin Investment Board
131
State of Wisconsin Investment Board
Wisconsin
$2.06M
APG Asset Management
132
APG Asset Management
Netherlands
$1.96M -$5.42M -16,364 -71%
PL
133
Parkwood LLC
Ohio
$1.91M +$188K +567 +11%
Swedbank
134
Swedbank
Sweden
$1.85M +$1.79M +5,398 New
JGGDR
135
JGP Global Gestao de Recursos
Brazil
$1.75M +$331 +1 +0%
PAM
136
Panagora Asset Management
Massachusetts
$1.7M +$123K +370 +8%
VOYA Investment Management
137
VOYA Investment Management
Georgia
$1.7M +$169K +511 +12%
US Bancorp
138
US Bancorp
Minnesota
$1.64M +$63.3K +191 +4%
Comerica Bank
139
Comerica Bank
Texas
$1.64M +$30.8K +93 +2%
First Trust Advisors
140
First Trust Advisors
Illinois
$1.53M -$1.77M -5,331 -54%
JMPWA
141
JP Morgan Private Wealth Advisors
California
$1.5M +$238K +720 +20%
Vontobel Holding
142
Vontobel Holding
Switzerland
$1.46M +$1.35M +4,085 New
Millennium Management
143
Millennium Management
New York
$1.46M +$1.4M +4,240 New
BCI
144
Brinker Capital Investments
Pennsylvania
$1.44M +$150K +454 +12%
TRCT
145
Tower Research Capital (TRC)
New York
$1.43M +$805K +2,430 +141%
FAM
146
Fred Alger Management
New York
$1.39M -$57.6K -174 -4%
Aberdeen Group
147
Aberdeen Group
United Kingdom
$1.37M +$14.6K +44 +1%
Fisher Asset Management
148
Fisher Asset Management
Washington
$1.35M +$768K +2,318 +143%
VF
149
Virtu Financial
New York
$1.24M +$1.2M +3,622 New
MC
150
Maverick Capital
Texas
$1.21M +$21.9K +66 +2%

ONC Hedge Fund Activity: Q2 2021 in Review

266 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in BeOne Medicines Ltd (ONC) for Q2 2021, worth a combined $19.1B — down 2.3% from $19.5B a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new ONC positions and 17 closed out — a net gain of 17 holders — while 109 added to existing stakes and 77 trimmed.

The largest buyer was Capital International Investors, adding an estimated $47.2M. The largest seller was Financial Perspectives, cutting an estimated $135M.

  • 266 institutional investors held BeOne Medicines Ltd (ONC) as of Q2 2021, up from 251 in Q1 2021.
  • Funds reported $19.1B of BeOne Medicines Ltd stock for Q2 2021, down 2.3% quarter-over-quarter.
  • 34 funds opened new BeOne Medicines Ltd positions in Q2 2021 and 17 closed out, a net change of +17 holders.
  • The largest BeOne Medicines Ltd buyer in Q2 2021 was Capital International Investors, an estimated $47.2M added.
  • The largest BeOne Medicines Ltd seller in Q2 2021 was Financial Perspectives, an estimated $135M sold.

Based on aggregated 13F filings for Q2 2021.